LYNPARZA

Identification of Lynparza

No description

Google image searchProduct monograph

Active ingredient

olaparib, 150 MG

DIN: 02475219

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 23-MAY-2018

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XK — Poly (ADP-ribose) polymerase (PARP) inhibitors (ATC, ATC/DDD)
• L01XK01 — OLAPARIB (ATC/DDD)

External Links for Lynparza

Search on Google

• Lynparza side effects
• Lynparza dosage
• olaparib side effects
• olaparib dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find lynparza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.